[1] Rajaram P, Subramanian R. Acute Liver Failure. Semin Respir Crit Care Med, 2018, 39:513-522. [2] Chao X, Wang H, Jaeschke H, et al. Role and mechanisms of autophagy in acetaminophen-induced liver injury. Liver Int. 2018,38:1363-1374. [3] Mazaleuskaya LL, Sangkuhl K, Thorn CF, et al. PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses. Pharmacogent Genomics, 2015, 25:416-426. [4] Yarema M, Chopra P, Sivilotti M, et al. Correction to: Anaphylactoid Reactions to Intravenous N-Acetylcysteine during Treatment for Acetaminophen Poisoning. J Med Toxicol, 2018, 14:173. [5] Fisher ES, Curry SC. Evaluation and treatment of acetaminophen toxicity. Adv Pharmacol, 2019, 85:263-272. [6] Malko P, Jiang LH. TRPM2 channel-mediated cell death: An important mechanism linking oxidative stress-inducing pathological factors to associated pathological conditions. Redox Biol, 2020, 37:101755. [7] Kheradpezhouh E, Ma L, Morphett A, et al. TRPM2 channels mediate acetaminophen-induced liver damage. Proc Natl Acad Sci USA, 2014, 111:3176-3181. [8] Kheradpezhouh E, Zhou FH, Barritt GJ, et al. Oxidative stress promotes redistribution of TRPM2 channels to the plasma membrane in hepatocytes. Biochem Biophys Res Commun, 2018, 503:1891-1896. [9] 吴晓明, 何强, 尤圣杰, 等.中药复方抗肝纤维化作用机制研究概述.北京中药,2021,06:675-680. [10] 沈莹, 柳湘洁, 雷超, 等. 黄芪总苷通过介导mTOR信号通路抑制H2O2诱导的大鼠心肌细胞自噬和凋亡.中国病理生理杂志,2019,35(09):1620-1624. [11] Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol, 2007, 47: 598-607. [12] 田爱平, 杨永峰. 慢性肝炎病理学分级分期评分系统比较.临床肝胆病杂志,2018,34: 2271-2277. [13] Lee WM. Acetaminophen (APAP) hepatotoxicity-Isn't it time for APAP to go away? J Hepatol, 2017, 67:1324-1331. [14] Lancaster EM, Hiatt JR, Zarrinpar A. Acetaminophen hepatotoxicity: an updated review. Arch Toxicol,2015,89:193-199. [15] Zhang L, Koyyalamudi SR, Jeong SC, et al. Immunomodulatory activities of polysaccharides isolated from Taxillus chinensis and Uncaria rhyncophylla. Carbohydr Polym, 2013, 98:1458-1465. [16] 姜辉, 顾胜龙, 张玉婷, 等. 黄芪化学成分和药理作用研究进展.安徽中医药大学学报,2020,39:93-96. [17] 鲍家卉, 王雪慧, 逄淑伟, 等. 黄芪粗提物对四氯化碳诱导的小鼠急性肝损伤的保护作用. 动物医学进展,2018,39:110-113. [18] Liang XY, Hong FF, Yang SL, et al. Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease. Diabetes Metab Syndr Obes, 2021, 14: 1871-1883. [19] Zhou B, Zhou DL, Wei XH, et al. Astragaloside IV attenuates free fatty acid-induced ER stress and lipid accumulation in hepatocytes via AMPK activation. Acta Pharmacol Sin. 2017 38:998-1008. [20] Miller BA, Cheung JY. TRPM2 protects against tissue damage following oxidative stress and ischaemia-reperfusion. J Physiol. 2016,594:4181-4191. |